On Tuesday, Kenvue Inc (KVUE) stock saw a decline, ending the day at $23.65 which represents a decrease of $-0.13 or -0.55% from the prior close of $23.78. The stock opened at $23.76 and touched a low ...

Divided Kings, screened as of November 8, 2024 represented all eleven Morningstar Sectors. Broker-estimated top-ten net-gains ...

SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders, announced ...

Pharmacycle has rolled out Australia's largest blister pack recycling initiative at Chemist Warehouse and My Chemist ...

Headlines,Institutional investors increase their stakes in Kenvue Inc.,XML Financial LLC acquires significant position in ...

Jefferies has recently initiated Kenvue Inc (KVUE) stock to Buy rating, as announced on September 24, 2024, according to Finviz. Earlier, on September 24, 2024, RBC Capital Mkts had reduced the stock ...

Summit Global Investments reduced its stake in Blackstone Inc. (NYSE:BX – Free Report) by 12.4% in the 3rd quarter, according ...

Fiera Capital Corp reduced its position in shares of Kenvue Inc. (NYSE:KVUE – Free Report) by 9.7% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange ...

As the U.S. stock market continues to reach record highs, fueled by a post-election rally and optimism surrounding potential policy changes, investors are keenly focused on identifying opportunities ...

Net income: US$383.0m (down 13% from 3Q 2023). Profit margin: 9.8% (down from 11% in 3Q 2023). EPS: US$0.20 (down from ...

Oral phenylephrine is used in over-the-counter products like Sudafed and Dayquil to help temporarily relieve the common ...

Bank of America Securities analyst Anna Lizzul maintained a Buy rating on Kenvue, Inc. (KVUE – Research Report) today. The ...